BioCentury
ARTICLE | Company News

Bio-ID Diagnostics Inc., Trovagene deal

January 16, 2012 8:00 AM UTC

TrovaGene will acquire MultiGen Diagnostics Inc., a subsidiary of Bio-ID based in San Diego, Calif., for 750,000 shares valued at $412,500 based on TrovaGene's close of $0.55 on Jan. 5, the day before...